Format

Send to

Choose Destination
Int J Surg. 2019 Mar;63:58-62. doi: 10.1016/j.ijsu.2019.01.006. Epub 2019 Jan 18.

Clinical pharmacist perspectives for optimizing pharmacotherapy within Enhanced Recovery After Surgery (ERAS®) programs.

Author information

1
Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: Lovely.Jenna@mayo.edu.
2
Grant Medical Center, Columbus, OH, 43215, USA. Electronic address: sara.jordan@ohiohealth.com.
3
Creighton University School of Pharmacy and Health Professions, Omaha, NE, 68178, USA. Electronic address: april.smith@creighton.edu.
4
Departments of Obstetrics & Gynecology and Oncology, Section Chief, Gynecologic Oncology, Secretary, ERAS(®) Society, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, Alberta, T2N 4N2, Canada. Electronic address: gregg.nelson@ahs.ca.
5
ERAS Society, Faculty of Medicine and Health, School of Health and Medical Sciences, Department of Surgery, Örebro University, Örebro, Sweden. Electronic address: olle.ljungqvist@oru.se.
6
St. Christopher's Hospital for Children, Philadelphia, PA, 19134, USA; Virginia Commonwealth University School of Pharmacy, Richmond, VA, 23298, USA. Electronic address: richard.parrish@americanacademic.com.

Abstract

One of the most durable approaches to perioperative enhanced recovery programming has culminated in the formation of perioperative organizations devoted to improvements in the quality of the surgical patient experience, such as the Enhanced Recovery After Surgery (ERAS®) Society. Members of the American College of Clinical Pharmacy (ACCP) Perioperative Care Practice and Research Network (PRN) and officials from the ERAS® Society present an opinion that: (1) identifies therapeutic options within each pharmacotherapy-intensive area of ERAS®; (2) generates applied research questions that would allow for comparative analyses of pharmacotherapy options within ERAS® programs; (3) proposes collaborative practice opportunities between key stakeholders in the surgical journey and clinical pharmacists to manage drug therapy problems and research questions; and (4) highlights examples of pharmacist-led cost savings attributed to ERAS® implementation. Clinical pharmacists, working in this manner with the perioperative team across the care continuum, have optimized pharmacotherapy towards measurable outcomes improvements, and stand ready to partner with inter-professional stakeholders and organizations to advance the care of our mutual patients.

PMID:
30665004
DOI:
10.1016/j.ijsu.2019.01.006

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center